CA2000548A1 - Bandage confortable et enduit - Google Patents

Bandage confortable et enduit

Info

Publication number
CA2000548A1
CA2000548A1 CA2000548A CA2000548A CA2000548A1 CA 2000548 A1 CA2000548 A1 CA 2000548A1 CA 2000548 A CA2000548 A CA 2000548A CA 2000548 A CA2000548 A CA 2000548A CA 2000548 A1 CA2000548 A1 CA 2000548A1
Authority
CA
Canada
Prior art keywords
coating material
conformable
conformable bandage
stinging
desiccation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000548A
Other languages
English (en)
Other versions
CA2000548C (fr
Inventor
Ann B. Salamone
Joseph C. Salamone
Alfred P. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rochal Industries Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2000548A1 publication Critical patent/CA2000548A1/fr
Application granted granted Critical
Publication of CA2000548C publication Critical patent/CA2000548C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/21—Silicone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Silicon Polymers (AREA)
CA002000548A 1988-10-12 1989-10-12 Bandage confortable et enduit Expired - Lifetime CA2000548C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25665188A 1988-10-12 1988-10-12
US07/256,651 1988-10-12
US07/416,924 US4987893A (en) 1988-10-12 1989-10-04 Conformable bandage and coating material
US07/416,924 1989-10-04

Publications (2)

Publication Number Publication Date
CA2000548A1 true CA2000548A1 (fr) 1990-04-12
CA2000548C CA2000548C (fr) 2000-12-05

Family

ID=26945505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000548A Expired - Lifetime CA2000548C (fr) 1988-10-12 1989-10-12 Bandage confortable et enduit

Country Status (8)

Country Link
US (1) US4987893A (fr)
EP (1) EP0438496B1 (fr)
JP (1) JP2918263B2 (fr)
AU (1) AU620653B2 (fr)
CA (1) CA2000548C (fr)
DE (1) DE68923456T2 (fr)
HK (1) HK1007690A1 (fr)
WO (1) WO1990003809A1 (fr)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5103812A (en) * 1988-10-12 1992-04-14 Rochal Industries, Inc. Conformable bandage and coating material
US5246705A (en) * 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5288827A (en) * 1993-02-17 1994-02-22 Ciba-Geigy Corporation Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
GB9411530D0 (en) * 1994-06-09 1994-08-03 Quayle Rachel A Use of polymers as film-forming barrier materials
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
EP1006935B1 (fr) * 1995-06-07 2005-01-26 Southern Biosystems, Inc. Systeme d'administration regulee d'un liquide de haute viscosite
US6730380B2 (en) 1996-02-20 2004-05-04 Safeskin Corp. Readily-donned elastomeric articles
US5948400A (en) * 1997-11-20 1999-09-07 Smith & Nephew Inc. Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition
AU1800099A (en) * 1997-11-25 1999-06-15 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
ATE338525T1 (de) * 1999-03-25 2006-09-15 3M Innovative Properties Co Nicht stechendes überzugsmittel
US6471985B2 (en) * 1999-06-04 2002-10-29 Bahman Guyuron Use of RTV silicone compositions for wound dressing
GB0003632D0 (en) * 2000-02-16 2000-04-05 Univ Hong Kong Science & Techn Dimeric compounds
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
UA81743C2 (uk) 2000-08-07 2008-02-11 Центокор, Инк. МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
US6602496B2 (en) 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US6942875B2 (en) * 2001-07-05 2005-09-13 Closure Medical Corporation Adhesive treatment for skin yeast infections
US6585967B2 (en) 2001-07-05 2003-07-01 Closure Medical Corporation Adhesive treatment for tinea cruris
US6746667B2 (en) 2001-07-05 2004-06-08 Closure Medical Corporation Adhesive treatment for tinea pedis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
US20040122382A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Elastomeric articles with beneficial coating on a surface
US9708410B2 (en) 2003-05-30 2017-07-18 Janssen Biotech, Inc. Anti-tissue factor antibodies and compositions
US20050031817A1 (en) * 2003-08-07 2005-02-10 Littleton Kermit R. Readily donned, powder-free elastomeric article
US20050129937A1 (en) * 2003-12-16 2005-06-16 Eastman Kodak Company Antimicrobial web for application to a surface
US7842749B2 (en) * 2004-08-02 2010-11-30 Poly-Med, Inc. Tissue protecting spray-on copolymeric film composition
US20060030808A1 (en) * 2004-08-09 2006-02-09 Aso Corporation Liquid bandage and tissue sealant
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
EP1833918B1 (fr) 2004-12-23 2011-09-28 Dow Corning Corporation Compositions saccharide-siloxane reticulables, et reseaux, revetements et articles obtenus a partir de celles-ci
US7318937B2 (en) * 2005-03-18 2008-01-15 Closure Medical Corporation Liquid coating compositions
JP5122444B2 (ja) 2005-05-23 2013-01-16 ダウ・コーニング・コーポレイション サッカリド−シロキサンコポリマーを含むパーソナルケア組成物
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP5567270B2 (ja) * 2005-08-17 2014-08-06 ロチャル インダストリーズ エルエルピー 液体コーティング材料及びキット
DE602006020490D1 (de) * 2005-12-07 2011-04-14 Rochal Ind Llp Anpassbarer verband und überzugsmaterial
EP2019678A4 (fr) 2006-05-23 2012-05-02 Dow Corning Nouvel agent filmogène en silicone pour la libération de principes actifs
MX2009009557A (es) * 2007-03-08 2010-08-10 Crescendo Therapeutics Llc Formulaciones de aposito para prevenir o reducir la cicatrizacion.
US8173146B2 (en) * 2007-04-23 2012-05-08 Safen'Simple LLC Stoma wipe and adhesive remover and method
US20080302827A1 (en) * 2007-06-06 2008-12-11 Gerrish Donald L Spray dispenser
EP2219622A1 (fr) 2007-12-06 2010-08-25 Durect Corporation Procédés utiles dans le traitement de la douleur, d'états rhumatismaux ou d'inflammations associées à un état chronique
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
EP2650014A2 (fr) 2008-06-20 2013-10-16 Wyeth LLC Compositions et procédés d'utilisation d'ORF1358 provenant de souches de streptocoques bêta-hémolytiques
US8003132B2 (en) 2008-06-30 2011-08-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an ultraviolet radiation-absorbing polymer
KR20160116056A (ko) 2008-08-14 2016-10-06 테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 항-ｉｌ-12/ｉｌ-23 항체
DE102008048338A1 (de) 2008-09-22 2010-03-25 Beiersdorf Ag Wundversorgungszubereitung mit verminderten Hautirritationen
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
DE102008060904A1 (de) * 2008-12-09 2010-06-10 Beiersdorf Ag Wasserlösliche Wirkstoffe in Sprühpflaster
PL2424948T3 (pl) 2009-04-27 2017-08-31 Avery Dennison Corporation Rozłączalny klej mający wielowarstwowe podłoże
US8957277B2 (en) 2009-04-27 2015-02-17 Avery Dennison Corporation Disruptable adhesive layer for fluid activated debonding
US8828425B2 (en) * 2010-02-02 2014-09-09 Poly-Med, Inc. In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
US8475774B2 (en) 2010-02-08 2013-07-02 Johnson & Johnson Consumer Companies, Inc. Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
US8853372B2 (en) 2010-08-23 2014-10-07 Dow Corning Corporation Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
JP5754665B2 (ja) * 2010-10-22 2015-07-29 アルケア株式会社 皮膚の痛み緩和用皮膜形成組成物
CA2843739A1 (fr) 2011-08-14 2013-02-21 Materials Modification, Inc. Procede et composition pour la formation in situ d'un blocage artificiel pour supprimer une perte de sang
CN103842456A (zh) 2011-09-30 2014-06-04 3M创新有限公司 适形涂层和组合物
US8263720B1 (en) * 2011-10-05 2012-09-11 Rochal Industries, Llp Sacrificial adhesive coatings
ES2568754T3 (es) 2011-10-31 2016-05-04 Avery Dennison Corporation Capa de adhesivo afectable para la desunión activada de fluido
CN104870567B (zh) 2012-10-22 2018-09-07 艾利丹尼森公司 分散在胶黏剂中的交联的微凝胶颗粒的杂化材料
US20150231300A1 (en) * 2012-10-28 2015-08-20 Peritech Pharma Ltd. Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
US8852648B2 (en) 2012-11-06 2014-10-07 Rochal Industries, Llp Delivery of biologically-active agents using volatile, hydrophobic solvents
WO2014140925A2 (fr) 2013-03-10 2014-09-18 Peritech Pharma Ltd. Compositions topiques et procédés de traitement de troubles topiques
US20140272129A1 (en) * 2013-03-15 2014-09-18 Apple Inc. Compliant permeable glue applicator
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
WO2015017044A1 (fr) * 2013-07-27 2015-02-05 Colby Lawrence A Systèmes et procédés pour accentuer la visibilité d'articles médicaux
US8877882B1 (en) 2013-10-04 2014-11-04 Rochal Industries Llp Non-self-adherent coating materials
WO2015097536A2 (fr) 2013-12-24 2015-07-02 Janssen Pharmaceutical Nv Anticorps et fragments anti-vista
US9962461B2 (en) 2014-03-10 2018-05-08 3M Innovative Properties Company Conformable coating composition
US10287398B2 (en) * 2014-12-30 2019-05-14 Momentive Performance Materials Inc. Siloxane coordination polymers
US9815045B2 (en) 2015-03-23 2017-11-14 Clariant Corporation Metal oxide catalyst material and processes for making and using same
WO2016164315A1 (fr) 2015-04-06 2016-10-13 3M Innovative Properties Company Compositions de gel filmogène amovibles et leurs procédés d'application
CA2990360C (fr) 2015-06-24 2024-02-13 Janssen Pharmaceutica Nv Anticorps et fragments anti-vista
WO2017137830A1 (fr) 2016-02-12 2017-08-17 Janssen Pharmaceutica Nv Anticorps anti-vista (b7h5)
CN109071653A (zh) 2016-03-29 2018-12-21 詹森生物科技公司 用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
WO2017175058A1 (fr) 2016-04-07 2017-10-12 Janssen Pharmaceutica Nv Anticorps anti-vista et fragments de ceux-ci, leurs utilisations et leurs procédés d'identification
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
CA3037961A1 (fr) 2016-09-30 2018-04-05 Janssen Biotech, Inc. Procede sur et efficace de traitement du psoriasis avec un anticorps specifique contre l'il-23
WO2018071278A1 (fr) * 2016-10-13 2018-04-19 3M Innovative Properties Company Compositions de gel de formation de film éliminable présentant des promoteurs d'adhérence
US11208474B2 (en) 2016-11-16 2021-12-28 Janssen Biotech, Inc. Method of treating psoriasis with anti-IL23 specific antibody
DE102017100443A1 (de) * 2017-01-11 2018-07-12 Madeleine Elixmann Flüssigpflaster, Auftragevorrichtung und deren Verwendung
WO2018140121A1 (fr) 2017-01-30 2018-08-02 Janssen Biotech, Inc. Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
MX2019009377A (es) 2017-02-07 2019-12-11 Janssen Biotech Inc Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa.
TW201922780A (zh) 2017-09-25 2019-06-16 美商健生生物科技公司 以抗ｉｌ１２／ｉｌ２３抗體治療狼瘡之安全且有效之方法
JP2021502349A (ja) 2017-11-06 2021-01-28 ヤンセン バイオテツク，インコーポレーテツド 抗ｉｌ２３特異的抗体で乾癬性関節炎を治療する安全かつ有効な方法
MX2020009265A (es) 2018-03-05 2020-10-01 Janssen Biotech Inc Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23.
US20200025776A1 (en) 2018-07-18 2020-01-23 Janssen Biotech, Inc. Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody
IL326284A (en) 2018-09-24 2026-04-01 Janssen Biotech Inc A safe and effective method for treating ulcerative colitis with an anti-IL12/IL23 antibody
IL283192B2 (en) 2018-11-20 2025-10-01 Janssen Biotech Inc A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody
MA54562A (fr) 2018-12-18 2021-10-27 Janssen Biotech Inc Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
JP7689074B2 (ja) 2019-01-15 2025-06-05 ヤンセン バイオテツク，インコーポレーテツド 若年性特発性関節炎の治療のための抗ｔｎｆ抗体、組成物、及び方法
WO2020152544A1 (fr) 2019-01-23 2020-07-30 Janssen Biotech, Inc. Compositions d'anticorps anti-tnf destinées à être utilisées dans des méthodes de traitement d'arthrite psoriasique
WO2020183269A1 (fr) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Procédés de fabrication pour la production de compositions d'anticorps anti-tnf
EA202192505A1 (ru) 2019-03-14 2022-03-29 Янссен Байотек, Инк. Способы получения композиций антитела к фно
EP3938384A4 (fr) 2019-03-14 2022-12-28 Janssen Biotech, Inc. Méthodes de fabrication permettant de produire des compositions d'anticorps anti-il12/il23
KR20210141998A (ko) 2019-03-14 2021-11-23 얀센 바이오테크 인코포레이티드 항-tnf 항체 조성물의 제조 방법
JP2022526493A (ja) 2019-03-18 2022-05-25 ヤンセン バイオテツク，インコーポレーテツド 抗ｉｌ１２／ｉｌ２３抗体を用いた小児被験者の乾癬の治療方法
JP7805788B2 (ja) 2019-05-23 2026-01-26 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
JP2022536279A (ja) 2019-06-03 2022-08-15 ヤンセン バイオテツク，インコーポレーテツド 乾癬性関節炎を治療するための抗ｔｎｆ抗体組成物及び方法
MX2021014882A (es) 2019-06-03 2022-03-25 Janssen Biotech Inc Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
MA56124A (fr) 2019-06-04 2022-04-13 Janssen Biotech Inc Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23
WO2021028752A1 (fr) 2019-08-15 2021-02-18 Janssen Biotech, Inc. Anticorps anti-tfn pour le traitement du diabète de type i
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CN111450310A (zh) * 2020-03-03 2020-07-28 劳龙斯(上海)医药科技有限公司 一种新型液体伤口敷料及其制备方法
US20210347880A1 (en) 2020-05-05 2021-11-11 Janssen Biotech, Inc. Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
IL298389A (en) 2020-05-21 2023-01-01 Janssen Biotech Inc Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
CN111714692B (zh) * 2020-07-07 2022-04-15 华熙生物科技股份有限公司 一种皮肤创面保护组合物及其制备方法
WO2022013745A1 (fr) 2020-07-13 2022-01-20 Janssen Biotech, Inc. Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23
US20220073603A1 (en) 2020-07-30 2022-03-10 Janssen Biotech, Inc. Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
CA3203561A1 (fr) 2021-01-12 2022-07-21 Adrian Neil Verity Systemes d'administration de medicament a liberation prolongee et procedes associes
IL305802A (en) 2021-03-12 2023-11-01 Janssen Biotech Inc A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
EP4305062A1 (fr) 2021-03-12 2024-01-17 Janssen Biotech, Inc. Méthode de traitement de patients souffrant de polyarthrite psoriasique ayant une réponse inadéquate à une thérapie par tnf avec un anticorps spécifique anti-il23
EP4367136A1 (fr) 2021-07-09 2024-05-15 Janssen Biotech, Inc. Procédés de fabrication pour produire des compositions d'anticorps anti-tnf
US12534524B2 (en) 2021-07-09 2026-01-27 Janssen Biotech, Inc. Manufacturing methods for producing anti-TNF antibody compositions
JP2024527581A (ja) 2021-07-09 2024-07-25 ヤンセン バイオテツク，インコーポレーテツド 抗ｉｌ１２／ｉｌ２３抗体組成物を生産するための製造方法
EP4423126B1 (fr) 2021-10-29 2026-05-06 Janssen Biotech, Inc. Méthodes de traitement de la maladie de crohn avec un anticorps spécifique anti-il23
EP4433501A1 (fr) 2021-11-15 2024-09-25 Janssen Biotech, Inc. Méthodes de traitement de la maladie de crohn au moyen d'un anticorps spécifique anti-il23
US20230159633A1 (en) 2021-11-23 2023-05-25 Janssen Biotech, Inc. Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
JP2025512860A (ja) 2022-03-30 2025-04-22 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３に特異的な抗体によって軽度から中等度の乾癬を治療する方法
EP4526342A1 (fr) 2022-05-18 2025-03-26 Janssen Biotech, Inc. Méthode d'évaluation et de traitement de l'arthrite psoriasique avec un anticorps il23
AU2023383916A1 (en) 2022-11-22 2025-07-10 Janssen Biotech, Inc. Method of treating ulcerative colitis with anti-il23 specific antibody
CA3249015A1 (en) 2024-03-20 2025-10-31 Janssen Biotech, Inc. Methods of treating crohn’s disease with anti-il23 specific antibody
WO2025262604A1 (fr) 2024-06-17 2025-12-26 Janssen Biotech, Inc. Méthodes de traitement de la maladie de crohn avec un anticorps spécifique anti-il23
CA3258952A1 (fr) 2024-06-27 2026-03-01 Janssen Biotech, Inc. Méthodes de traitement de la colite ulcéreuse au moyen d’un anticorps spécifique anti-il-23
CN120003104B (zh) * 2025-04-15 2025-09-09 南京斯瑞奇医疗用品有限公司 一种高透气性粘体式低敏胶贴及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577516A (en) * 1969-12-02 1971-05-04 Nat Patent Dev Corp Preparation of spray on bandage
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
CA1039189A (fr) * 1973-08-31 1978-09-26 Beiersdorf Aktiengesellschaft Solution de polymere pulverisable et formant une pellicule utilisable comme pansement sur les plaies
JPS5528918A (en) * 1978-08-18 1980-02-29 Kuraray Co Ltd Coating material
US4303066A (en) * 1979-06-28 1981-12-01 National Patent Development Corporation Burn dressing
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4393048A (en) * 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4291025A (en) * 1980-04-11 1981-09-22 Laclede Professional Products, Inc. Agar gel topical dressing
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4650817A (en) * 1982-07-16 1987-03-17 C. R. Bard, Inc. Physiologically compatible adhesive composition
FR2589737A1 (fr) * 1985-11-12 1987-05-15 Dow Corning Sa Procedes de fabrication de pansements
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing

Also Published As

Publication number Publication date
DE68923456T2 (de) 1995-12-14
EP0438496A1 (fr) 1991-07-31
JPH04501076A (ja) 1992-02-27
US4987893A (en) 1991-01-29
WO1990003809A1 (fr) 1990-04-19
EP0438496A4 (en) 1991-10-09
HK1007690A1 (en) 1999-04-23
AU620653B2 (en) 1992-02-20
CA2000548C (fr) 2000-12-05
AU4423789A (en) 1990-05-01
EP0438496B1 (fr) 1995-07-12
DE68923456D1 (de) 1995-08-17
JP2918263B2 (ja) 1999-07-12

Similar Documents

Publication Publication Date Title
CA2000548A1 (fr) Bandage confortable et enduit
GB2194446B (en) Wound dressing, its preparation and use
US5762955A (en) Method for application and maintenance of medication on body tissue
US5103812A (en) Conformable bandage and coating material
HK1007690B (en) Conformable bandage and coating material
IE870722L (en) Wound dressing
CA2170838A1 (fr) Pansements occlusifs possedant une structure speciale
CA1306195C (fr) Traitement occlusif etendu pour problemes cutanes
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
Sawada et al. A silicone gel sheet dressing containing an antimicrobial agent for split thickness donor site wounds
Williams 3M Cavilon No Sting Barrier Film in the protection of vulnerable skin
US20010051179A1 (en) Method for preventing the spread of infectious microorganisms using cyanoacrylate
AU8411391A (en) Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
ATE220548T1 (de) Verwendung von oxazolidinonen zur herstellung eines arzneimittels zur transdermalen darreichung
CA2075082A1 (fr) Systeme de traitement par occlusion prolongee
Raab A new hydrophilic copolymer membrane for dermabrasion
RU94006811A (ru) Ранозаживляющее покрытие на основе полимера и фермента губка "цитокол"
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
Nangia et al. Laboratory evaluation of a new hydrogel-type skin substitute
RU2115436C1 (ru) Средство для лечения ран
Williams Hydrocoll: a ‘new breed’of hydrocolloid wound dressing
FR2392674A1 (fr) Compositions pharmaceutiques a base d'elastine
Buehler et al. The" Sulfamylon Sandwich"—A Laminated Mafenide-Saline Dressing
Lawrence et al. An adherent semipermeable film dressing for burns

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry